Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose IL-2 in Systemic Lupus Erythematosus
NCT02084238Completed
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2013
- Primary completion
- Nov 2014
- Countries
- 1
01
Overview
Open-label trial of aldesleukin in systemic lupus erythematosus (SLE), sponsored by Peking University People's Hospital. Started Aug 2013; status: completed.
02
Drugs
aldesleukin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02084238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084238.